Parallax Volatility Advisers
KZR

Parallax Volatility Advisers’s Kezar Life Sciences KZR Stock Holding History

Parallax Volatility Advisers’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-7,144
Closed -$85K – 2349
2023
Q3 		$85K Buy
7,144
+5,712
+399% +$101K ﹤0.01% 1957
2023
Q2 		$35.1K Buy
+1,432
New +$37.3K ﹤0.01% 2104

Other funds holding KZR

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Parallax Volatility Advisers's KZR Position: Q4 2023 in Review

Parallax Volatility Advisers sold out of Kezar Life Sciences (KZR) in Q4 2023, closing a stake of 7,144 shares — an estimated $85K sold.

Parallax Volatility Advisers first reported a position in KZR in Q2 2023 and held it in 2 quarters. The position peaked at $85K in Q3 2023. 81 funds tracked by Wall St. Rank hold KZR as of Q4 2023.

  • Parallax Volatility Advisers reported no remaining Kezar Life Sciences position as of Q4 2023 after selling out during the quarter.
  • Parallax Volatility Advisers sold 7,144 Kezar Life Sciences shares in Q4 2023, an estimated $85K.
  • Parallax Volatility Advisers first reported a position in Kezar Life Sciences in Q2 2023 and held it in 2 quarters.
  • Parallax Volatility Advisers's Kezar Life Sciences position peaked at $85K in Q3 2023.
  • 81 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q4 2023.

Based on Parallax Volatility Advisers's 13F filing for Q4 2023, filed 14 Feb 2024.